138 related articles for article (PubMed ID: 35469452)
21. Recommendations for fertility preservation in patients with lymphomas.
Schmidt KT; Andersen CY;
J Assist Reprod Genet; 2012 Jun; 29(6):473-7. PubMed ID: 22562284
[TBL] [Abstract][Full Text] [Related]
22. Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
Lambertini M; Cinquini M; Moschetti I; Peccatori FA; Anserini P; Valenzano Menada M; Tomirotti M; Del Mastro L
Eur J Cancer; 2017 Jan; 71():25-33. PubMed ID: 27940355
[TBL] [Abstract][Full Text] [Related]
23. Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma.
Policiano C; Subirá J; Aguilar A; Monzó S; Iniesta I; Rubio Rubio JM
J Assist Reprod Genet; 2020 Jul; 37(7):1755-1761. PubMed ID: 32488563
[TBL] [Abstract][Full Text] [Related]
24. Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development.
Jensen AK; Rechnitzer C; Macklon KT; Ifversen MR; Birkebæk N; Clausen N; Sørensen K; Fedder J; Ernst E; Andersen CY
Hum Reprod; 2017 Jan; 32(1):154-164. PubMed ID: 27816923
[TBL] [Abstract][Full Text] [Related]
25. [The possibility of the fertility preservation in young cancer patients based on practice of oncofertility treatment].
Suzuki N; Yoshioka N; Sugishita Y; Takae S; Horage Y; Igarashi S; Hashimoto S; Morimoto Y; Ishizuka B
Gan To Kagaku Ryoho; 2012 Feb; 39(2):151-7. PubMed ID: 22333623
[TBL] [Abstract][Full Text] [Related]
26. Do cancer therapies damage the uterus and compromise fertility?
Griffiths MJ; Winship AL; Hutt KJ
Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
[TBL] [Abstract][Full Text] [Related]
27. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of ovarian reserve before and after chemotherapy.
Berjeb KK; Debbabi L; Braham M; Zemni Z; Chtourou S; Hannachi H; Hamdoun M; Ayadi M; Kacem K; Zhioua F; Fadhlaoui A; Bahri O; Chakroun N
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102035. PubMed ID: 33307239
[TBL] [Abstract][Full Text] [Related]
29. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
Sinha N; Letourneau JM; Wald K; Xiong P; Imbar T; Li B; Harris E; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Oct; 35(10):1861-1868. PubMed ID: 30066303
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
[TBL] [Abstract][Full Text] [Related]
31. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation.
Wallace WH; Smith AG; Kelsey TW; Edgar AE; Anderson RA
Lancet Oncol; 2014 Sep; 15(10):1129-36. PubMed ID: 25130994
[TBL] [Abstract][Full Text] [Related]
32. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
34. Does type of cancer affect ovarian response in oncofertility patients?
Hussein RS; Zhao Y; Khan Z
J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
[TBL] [Abstract][Full Text] [Related]
36. Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant.
Brodigan K; Kapadia M; Frazier AL; Laufer MR; Yu R; Weil BR; Ginsburg ES; Duncan C; Lehmann L
Transplant Cell Ther; 2021 Aug; 27(8):696.e1-696.e4. PubMed ID: 33864966
[TBL] [Abstract][Full Text] [Related]
37. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
Clowse ME; Behera MA; Anders CK; Copland S; Coffman CJ; Leppert PC; Bastian LA
J Womens Health (Larchmt); 2009 Mar; 18(3):311-9. PubMed ID: 19281314
[TBL] [Abstract][Full Text] [Related]
38. Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function.
Campos SM; Berlin S; Matulonis UA; Muto MG; Pereira L; Mosquera MM; Horowitz N
J Psychosoc Oncol; 2012; 30(4):387-401. PubMed ID: 22747104
[TBL] [Abstract][Full Text] [Related]
39. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE).
Clark RA; Mostoufi-Moab S; Yasui Y; Vu NK; Sklar CA; Motan T; Brooke RJ; Gibson TM; Oeffinger KC; Howell RM; Smith SA; Lu Z; Robison LL; Chemaitilly W; Hudson MM; Armstrong GT; Nathan PC; Yuan Y
Lancet Oncol; 2020 Mar; 21(3):436-445. PubMed ID: 32066539
[TBL] [Abstract][Full Text] [Related]
40. Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments.
Silva C; Ribeiro Rama AC; Reis Soares S; Moura-Ramos M; Almeida-Santos T
J Ovarian Res; 2019 Oct; 12(1):102. PubMed ID: 31672154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
